Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Altan

Showing results (101-110 of 153) with videos related to

Pageof 16
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung CancerJames W Welsh, John V Heymach, Dawei Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2022
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trialYufei Liu, Luyang Yao, Neda Kalhor, et al.
Cancers|March 13, 2024
Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and ImmunotherapyKang Qin, Kaiwen Wang, Shenduo Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2023
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic CarcinomaRenata Ferrarotto, Luana G Sousa, Lei Feng, et al.
Frontiers in Immunology|December 28, 2023
Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse eventsMehmet Altan, Quan-Zhen Li, Qi Wang, et al.
The Oncologist|March 23, 2023
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center ExperienceMirella Nardo, Bulent Yilmaz, Blessie Elizabeth Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 TrialMarcelo V Negrao, Alvaro G Paula, David Molkentine, et al.
JCO Precision Oncology|August 11, 2021
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic ProfilingHai T Tran, Vincent K Lam, Yasir Y Elamin, et al.
Journal for Immunotherapy of Cancer|September 6, 2019
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapyHari Menon, Dawei Chen, Rishab Ramapriyan, et al.
Cancers|May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil ModelHui Li, Morteza Salehjahromi, Myrna C B Godoy, et al.
Pageof 16

Showing results (101-110 of 153) with videos related to

Sort By:
Pageof 16
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 13, 2019
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung CancerJames W Welsh, John V Heymach, Dawei Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2022
Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trialYufei Liu, Luyang Yao, Neda Kalhor, et al.
Cancers|March 13, 2024
Clinical Benefit from Docetaxel +/- Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and ImmunotherapyKang Qin, Kaiwen Wang, Shenduo Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2023
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic CarcinomaRenata Ferrarotto, Luana G Sousa, Lei Feng, et al.
Frontiers in Immunology|December 28, 2023
Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse eventsMehmet Altan, Quan-Zhen Li, Qi Wang, et al.
The Oncologist|March 23, 2023
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center ExperienceMirella Nardo, Bulent Yilmaz, Blessie Elizabeth Nelson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 TrialMarcelo V Negrao, Alvaro G Paula, David Molkentine, et al.
JCO Precision Oncology|August 11, 2021
Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic ProfilingHai T Tran, Vincent K Lam, Yasir Y Elamin, et al.
Journal for Immunotherapy of Cancer|September 6, 2019
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapyHari Menon, Dawei Chen, Rishab Ramapriyan, et al.
Cancers|May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil ModelHui Li, Morteza Salehjahromi, Myrna C B Godoy, et al.
Pageof 16